December 6, 2021
Clinical laboratories are unsung heroes of COVID-19In normal times, clinical laboratories, including pathologists, laboratory directors and clinical laboratory scientists, function in the background. We are not patient facing but provide important diagnostic tools and insights to our partner physicians and nurses. In a war analogy, we are the code breakers that support the front-line troops. Pathology is detective work, investigating the best test, understanding regulations, and figuring out the diagnosis in a timely manner. COVID-19 thrust laboratory professionals into the unknown with an...
November 17, 2021
The American Association for Cancer Research (AACR) today announced the appointment of Massimo Loda, MD, as the Editor-in-Chief of Molecular Cancer Research, one of the nine highly esteemed journals published by the AACR. Loda officially began his term on August 1.Massimo Loda, MDChairman of Pathology and Laboratory MedicineMolecular Cancer Research publishes articles describing novel basic cancer research discoveries of broad interest to the field. The journal prioritizes analyses performed at the molecular and cellular level that reveal novel mechanistic insights into pathways and processes...
November 17, 2021
Dr. C. Richard Minick (1936-2021), Professor Emeritus of Pathology and Laboratory Medicine at Weill Cornell Medicine, Cornell University, died on Long Island, New York on November 5, 2021 at the age of 85. Dr. Minick will be remembered for his extraordinary contributions to the role of cell injury and inflammation in the pathogenesis of atherosclerosis. His innovative work helped to focus scientific research on the role of immunological and viral injury in the development of cardiovascular disease. Dr. Minick published 42 substantive research papers and 19 book chapters in the field of...
September 28, 2021
Convalescent plasma did not reduce the risk of intubation or death for hospitalized COVID-19 patients in a large, international clinical trial conducted by Weill Cornell Medicine and NewYork-Presbyterian investigators in collaboration with lead investigators at McMaster University.
September 23, 2021
Turning off a defense mechanism that protects colorectal cancer tumors from being discovered by immune cells could be a possible strategy for treating the disease, according to a new study by Weill Cornell Medicine investigators. Because immunotherapy reactivates immune cells near a tumor, but fails when those cells aren’t present in significant numbers, the new approach could potentially complement this type of treatment or work on its own.
September 14, 2021
Congratulations to the dozens of WCM Pathology members who co-authored or volunteered for the new study, "More rapid, robust and sustainable antibody responses to mRNA COVID-19 vaccine in convalescent COVID-19 individuals," in The Journal of Clinical Invesitgation.
September 8, 2021
The AIDS Malignancy Consortium (AMC) Executive Committee selected our colleague Dr. Paul D. Simonson to participate in its prestigious 2021 Lab/Translational Scholar Award Program!
September 1, 2021
A cellular protein whose normal function appears to suppress bone formation may be a potential new target for treating osteoporosis, suggests a collaborative study led by Weill Cornell Medicine and NewYork-Presbyterian investigators.
July 30, 2021
Congratulations to Sarina Yang, PhD, a 2021 ASCP 40 Under Forty Honoree! What an achievement!He Sarina Yang, PhD Assistant Professor of Pathology and Laboratory MedicineThe ASCP 40 Under Forty program recognizes members under the age of 40 for their achievements and leadership qualities that are making an impact on pathology and laboratory medicine. Forty pathologists, laboratory professionals and residents are chosen annually through an application or nomination process. The program has recognized worthy members of the laboratory team both nationally and internationally. From the 40 Under...
July 24, 2021
Five Weill Cornell Medicine instructors and junior faculty seeking to pursue independent research careers have received 2021 JumpStart Career Development awards.Nicholas Brady, PhD Instructor in Pathology and Laboratory MedicineThe Jumpstart Program supports investigators during the critical period of career development spanning from the completion of research training to the early years on faculty at Weill Cornell Medicine. By providing one year of initial funding, with the opportunity of up to $300,000 over three years, the program aims to assist investigators as they apply for a National...